Combination approaches addressing multiple mechanisms simultaneously (neuroprotection plus antioxidant plus anti-inflammatory) potentially most effective for moderate disease
CJC-1295 has been marketed with and without drug affinity complex (DAC) technology, which extends its half-life and resultant therapeutic window as follows [2]: CJC-1295 No DAC: CJC-1295 No DAC contains only straight CJC-1295 with a D-Ala at the 2-position, a Gln at the 8-position (to reduce asparagine rearrangement), an Ala at position 15 (to enhance bioactivity), and a Leu at position 27 (to prevent methionine oxidation)
Visible hyperpigmentation
Current medical guidance is clear that HCG is not FDA-approved for weight loss and that severe calorie restriction, not HCG itself, is likely the main driver behind short-term scale changes in these programs
PHD domains and E3 ubiquitin ligases: viruses make the connection
[] Another 8-week trial involving 52 benign prostatic hyperplasia (BPH) patients demonstrated that combined supplementation of lycopene and FruHis resulted in a more significant reduction in insulin-like growth factor 1 (IGF-1), total prostate-specific antigen (TPSA), symptom score, body mass index (BMI), and waist circumference (WC) compared with either supplement alone, with a notable effect observed specifically for IGF-1
